Sheng Ding

Title: **Innovative Contributions of Sheng Ding in Pharmaceutical Formulations**

Introduction

Sheng Ding, an accomplished inventor based in Changzhou, China, has made notable strides in the field of pharmaceutical engineering. With a focus on enhancing drug formulation processes, he holds one patent that signifies his commitment to innovation in medicine.

Latest Patents

Sheng Ding's patent, titled "Method of preparing itraconazole preparation," outlines an advanced technique for creating an itraconazole formulation. This method involves dissolving a combination of itraconazole and L-ascorbic acid in a mixed solvent of dichloromethane and methanol. The process includes adding hydroxypropyl methylcellulose and pluronic F-127 before injecting carbon dioxide into a crystallization autoclave using a supercritical fluid crystallization system. By spraying the solution into the autoclave, composite particles are formed, which are then collected for encapsulation. This innovative approach results in a formulation featuring decreased particle size and improved bioavailability, demonstrating significant advancements in drug delivery systems.

Career Highlights

Throughout his career, Sheng Ding has contributed to the pharmaceutical industry by working with notable companies, including Changzhou Pharmaceutical Factory Co., Ltd. and Crystec Ltd. His experience in these organizations has honed his skills and expertise, enabling him to develop effective and innovative pharmaceutical solutions.

Collaborations

Sheng Ding has also collaborated with talented professionals during his career, including Xuezhi Yin and Linda Sharon Daintree. These partnerships reflect the importance of teamwork in advancing research and innovation within the pharmaceutical sector.

Conclusion

Sheng Ding stands out as an inventor dedicated to enhancing pharmaceutical formulations. His patent for methodically preparing itraconazole preparation showcases his innovative approach and commitment to improving drug effectiveness. Through his career and collaborations, he continues to contribute significantly to the field, inspiring future innovations in pharmaceutical development.